Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction

Bernadett Blaskó1, Ragnhildur Kolka, Perla Thorbjornsdottir

  • 1Research Group of Inflammation Biology and Immunogenomics, Semmelweis University and Hungarian Academy of Sciences, Budapest, Hungary.

International Immunology
|November 23, 2007
PubMed

Insights

Low C4B gene copy number is a significant risk factor for 1-year mortality after acute myocardial infarction, particularly in smoking Icelandic patients. The LTA 252 G allele did not show this association in the studied Caucasian population.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Immunogenetics

Background:

  • Genetic factors influence risk of death after acute coronary syndrome.
  • Low C4B gene copy number (C4B*Q0 genotype) is linked to cardiovascular disease morbidity and mortality.
  • The LTA +252 G allele has been associated with CVD mortality in Oriental populations.

Purpose of the Study:

  • To investigate the association between complement component C4 gene copy number (C4A and C4B) and lymphotoxin-alpha (LTA) gene polymorphism with mortality after acute myocardial infarction (AMI).

Main Methods:

  • Studied 142 Icelandic patients post-AMI.
  • Quantified C4A and C4B gene copy numbers using real-time PCR.
  • Assessed LTA +252 A>G single-nucleotide polymorphism (SNP) via PCR-RFLP.

Main Results:

  • The C4B*Q0 genotype was strongly associated with 1-year mortality (HR 3.50, P=0.008), specifically in patients who had ever smoked.
  • C4A gene copy number did not correlate with increased mortality risk.
  • LTA +252 SNP did not confer an increased risk of mortality after AMI.

Conclusions:

  • Low C4B gene copy number is a significant risk factor for short-term mortality post-AMI in smoking Icelandic patients.
  • The LTA +252 G allele is not identified as a risk factor for AMI mortality in this Caucasian cohort.
Abstract